Iradimed (IRMD) EBT Margin Growth (3y) (2016 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | -305.00 |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | -9.00 |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | -222.00 |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 923.00 |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | -480.00 |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 2,114.00 |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 1,391.00 |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | -176.00 |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 329.00 |
| 10 | Iradimed | 1.17 Bn | 1.11 Bn | 16.81 Mn | 724.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 724.00 |
| Dec 31, 2025 | 269.00 |
| Sep 30, 2025 | 281.00 |
| Jun 30, 2025 | 305.00 |
| Mar 31, 2025 | 561.00 |
| Dec 31, 2024 | 650.00 |
| Sep 30, 2024 | 666.00 |
| Jun 30, 2024 | 1,603.00 |
| Mar 31, 2024 | 1,059.00 |
| Dec 31, 2023 | 2,478.00 |
| Sep 30, 2023 | 2,851.00 |
| Jun 30, 2023 | 7,569.00 |
| Mar 31, 2023 | 1,848.00 |
| Dec 31, 2022 | 1,003.00 |
| Sep 30, 2022 | 522.00 |
| Jun 30, 2022 | 626.00 |
| Mar 31, 2022 | 582.00 |
| Dec 31, 2021 | 373.00 |
| Sep 30, 2021 | 879.00 |
| Jun 30, 2021 | -416.00 |
| Mar 31, 2021 | 334.00 |
| Dec 31, 2020 | -761.00 |
| Sep 30, 2020 | 636.00 |
| Jun 30, 2020 | -4,916.00 |
| Mar 31, 2020 | 1,368.00 |
| Dec 31, 2019 | -367.00 |
| Sep 30, 2019 | -736.00 |
| Jun 30, 2019 | -720.00 |
| Mar 31, 2019 | -2,015.00 |
| Dec 31, 2018 | -1,519.00 |
| Sep 30, 2018 | -2,030.00 |
| Jun 30, 2018 | -1,292.00 |
| Mar 31, 2018 | -1,720.00 |
| Dec 31, 2017 | 1,063.00 |
| Sep 30, 2017 | -648.00 |
| Jun 30, 2017 | -2,819.00 |
| Mar 31, 2017 | -2,731.00 |
| Dec 31, 2016 | 558.00 |
| Sep 30, 2016 | 1,864.00 |
| Jun 30, 2016 | 488.00 |